NCT07099001Completed
Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay
Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay: A QURE Virtual Patient Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 7 Jan 2026
Brief summary (registry, in English)
This is a national-level research study of neurologists and dementia specialists. The purpose of this study is to assess the clinical evaluation and management recommendations made by practicing providers for patient simulations with symptoms of cognitive decline.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 178 (actual)
- First submitted
- 16 Jul 2025
- Start date
- 8 Aug 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Qure Healthcare, LLC
- Diseases
- Alzheimer disease
- NCT number
- NCT07099001
What you commit to
- Study type: Interventional
- Participants enrolled: 178
- From 8 Aug 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Board-certified in neurology for less than two years
- Board certification in neurology over 35 years ago
- Unable to read English
- Unable to access the internet
- Not practicing in the United States
- Not averaging at least 20 hours per week of clinical or patient care duties over the past six months
- Participating in a clinical research study of the AD assay
- Do not voluntarily consent to participate in this study
Who the study is looking for
- Board-certified in neurology for at least two years (and no more than 35 years
- Average at least 20 hours per week of clinical and patient care duties over the past six months
- Routinely evaluate patients at risk for Alzheimer's disease
- Practicing in the United States
- Able to read English
- Access to the internet
- Not participating in a clinical research study of the AD assay
- Informed, signed, and voluntarily consented to participate in this study
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| QURE Healthcare Coordinator of this site? Confirm its status | St Louis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.